NEW YORK, NY -- (MARKET WIRE) -- January 04, 2007 -- China Aoxing Pharmaceutical Company, Inc. (“Aoxing”) (OTCBB: CAXG) announced the appointment of Hui (David) Shao, Ph.D., MBA, as Senior Vice President of Finance, effective immediately. Dr. Shao has more than 10 years of pharmaceutical industry experience, including a senior scientist position at Roche Pharmaceuticals and most recently as a healthcare analyst at Wall Street investment firms in New York City. In his new role, Dr. Shao will assist Aoxing’s Chief Financial Officer, Yue Zhenjiang, with the financial and accounting operations, as well as corporate communications at China Aoxing Pharmaceutical Company.
